---
layout: post
title: "Health Care Sector Daily Brief: Top Market News for 2026-01-08"
date: "2026-01-08"
sector: "Health Care"
etf: "XLV"
description: "Today's Health Care sector headlines: 3 stories covering soley, series, fierce, biotech, lilly. Free daily market intelligence for investors."
keywords: "Health Care, XLV, stock market news, sector news, 2026-01-08, market intelligence, investing news"
og_title: "Health Care Daily Brief — 2026-01-08"
og_description: "3 breaking stories in Health Care: Lilly to acquire Ventyx Biosciences to advance ora..., Fierce Biotech Fundraising Tracker '26: Soley sees..., GSK's chronic hepatitis B therapy shows promise in..."
permalink: /2026-01-08/health-care/
---

# Health Care Sector Daily Brief
## 2026-01-08 — 3 Stories

**Today's highlights:** soley, series, fierce, biotech, lilly

---

### 1. Lilly to acquire Ventyx Biosciences to advance oral therapies targeting inflammatory-mediated diseases - Eli Lilly

**Source:** [Google News (Business)](https://news.google.com/rss/articles/CBMiuAFBVV95cUxQYjdwYWFSNE1WN3JMRkFzUnk5NGk4cWo3N05TMGhrdHphaFJDajVYeUZDRnR3TG43Q0ZXUm1lZXN6QXM4LURmWldsX1NkaWgyY3R5VWpjd2Z4RmZOY1ZuZWZ3NjNYLUVYUm5NdHg0dFVURlpMbnY1dU5mUVJtV0lOLUVlNEk2U0RDMklxSXNrcEVIUW8yUWNYeE05TUZQOWhVMXhvaFZfaWdwbXJYUlVOUGZ4Z2h3UXA5?oc=5) · 2026-01-07
> Lilly to acquire Ventyx Biosciences to advance oral therapies targeting inflammatory-mediated diseases Eli Lilly View Full Coverage on Google News

[Read full article →](https://news.google.com/rss/articles/CBMiuAFBVV95cUxQYjdwYWFSNE1WN3JMRkFzUnk5NGk4cWo3N05TMGhrdHphaFJDajVYeUZDRnR3TG43Q0ZXUm1lZXN6QXM4LURmWldsX1NkaWgyY3R5VWpjd2Z4RmZOY1ZuZWZ3NjNYLUVYUm5NdHg0dFVURlpMbnY1dU5mUVJtV0lOLUVlNEk2U0RDMklxSXNrcEVIUW8yUWNYeE05TUZQOWhVMXhvaFZfaWdwbXJYUlVOUGZ4Z2h3UXA5?oc=5)

---

### 2. Fierce Biotech Fundraising Tracker '26: Soley sees $200M series C; Rakuten rakes in $100M - Fierce Biotech

**Source:** [Google News (Business)](https://news.google.com/rss/articles/CBMigAFBVV95cUxPWnNIYUVmZkJnUzFkM3dqNFpZaFZRRUdTUWNxb2lMeDY4NklMMGJobEM0NDU3LUQ2ZmRhYjNNaTlRM3N4MzZHOExoV3BGQXk1a1dKNDFHaHlrT0RZX3pYd0g0OVhlNnZobEtEdzBtLTh3ZnRsSWFpbGNjRVVpU1VIMA?oc=5) · 2026-01-07
> Fierce Biotech Fundraising Tracker '26: Soley sees $200M series C; Rakuten rakes in $100M Fierce Biotech Exclusive: Soley emerges with $200M Series C and broad pipeline for 'stress clock' Endpoints News Soley Therapeutics Raises $200M in Series C Financing FinSMEs Soley Therapeu…

[Read full article →](https://news.google.com/rss/articles/CBMigAFBVV95cUxPWnNIYUVmZkJnUzFkM3dqNFpZaFZRRUdTUWNxb2lMeDY4NklMMGJobEM0NDU3LUQ2ZmRhYjNNaTlRM3N4MzZHOExoV3BGQXk1a1dKNDFHaHlrT0RZX3pYd0g0OVhlNnZobEtEdzBtLTh3ZnRsSWFpbGNjRVVpU1VIMA?oc=5)

---

### 3. GSK's chronic hepatitis B therapy shows promise in key studies, analysts await full data - Reuters

**Source:** [Google News (Business)](https://news.google.com/rss/articles/CBMizwFBVV95cUxOZTdxcTZyTkVjNHRpSENweWpFUzlZd1c3RWtxWmppcjdsdm55SFFkOGh0NW1hWmdGS21CZUFjWkFfWkNjMVhKODItdXJDUXFyeUpIaWlMU0V6RTQ4N2FPNVRnTVgtalRZUWhPS0NVSGhmTHdkb3ctTzRCUUV3OVdSUU0yczl4R0pDVHJUQXRUVTVsZ2Z2ZFZPQ1dXdHRxNllfR0pCeEd1LU8xR2FJUXBOTkhFbmhMUHBiVFN6TDlUSUR0V2hhcTJpOHZ1cDM0SlU?oc=5) · 2026-01-07
> GSK's chronic hepatitis B therapy shows promise in key studies, analysts await full data Reuters GSK Scores Phase III Win in Hep B Yahoo Finance GSK's 'functional cure' for hep B proves worth in phase 3 trials setting up approval push Fierce Biotech GSK, Ionis Achieve Functional…

[Read full article →](https://news.google.com/rss/articles/CBMizwFBVV95cUxOZTdxcTZyTkVjNHRpSENweWpFUzlZd1c3RWtxWmppcjdsdm55SFFkOGh0NW1hWmdGS21CZUFjWkFfWkNjMVhKODItdXJDUXFyeUpIaWlMU0V6RTQ4N2FPNVRnTVgtalRZUWhPS0NVSGhmTHdkb3ctTzRCUUV3OVdSUU0yczl4R0pDVHJUQXRUVTVsZ2Z2ZFZPQ1dXdHRxNllfR0pCeEd1LU8xR2FJUXBOTkhFbmhMUHBiVFN6TDlUSUR0V2hhcTJpOHZ1cDM0SlU?oc=5)

---


## About This Brief

This daily Health Care sector intelligence brief is auto-generated from 9+ trusted financial news sources. Updated every morning at 8 AM UTC.

**Related:** [View all sectors for 2026-01-08](/2026-01-08/) | [Subscribe via RSS](/feed.xml)
